MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q3
hinzugefügt 16.05.2026
Psychemedics Corporation Operativer Cashflow 2011-2026 | PMD
Operativer Cashflow Jährlich Psychemedics Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 929 K | -1.48 M | 4.89 M | 414 K | -4.08 M | 4.31 M | 7.93 M | 9.15 M | 9.27 M | 4.58 M | - | - | 3.09 M | 3.94 M | 3.3 M | 2.4 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.27 M | -4.08 M | 3.47 M |
Operativer Cashflow Vierteljährlich Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -90 K | -353 K | -473 K | - | -2.14 M | -1.18 M | -225 K | - | 3 M | 662 K | 345 K | - | -151 K | 237 K | -413 K | - | -5.22 M | -3.73 M | -413 K | - | 3.36 M | 1.69 M | 368 K | - | 4.01 M | 3.6 M | 1.41 M | - | 7.12 M | 3.43 M | 4.4 M | - | 6.07 M | - | - | - | - | - | - | - | - | - | - | - | 3.85 M | 2.15 M | 609 K | - | 2.48 M | 1.45 M | 167 K | - | 781 K | 854 K | -90.3 K |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.12 M | -5.22 M | 1.1 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 88.28 | -4.53 % | $ 4.13 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 5.63 | -2.26 % | $ 7.49 M | USA |
 |
Castle Biosciences
CSTL
|
64.3 M | $ 21.01 | -2.73 % | $ 609 M | USA |
 |
Fulgent Genetics
FLGT
|
-102 M | $ 19.15 | -1.79 % | $ 589 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 125.61 | -5.6 % | $ 15.7 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.67 | -6.7 % | $ 7.39 M | USA |
 |
Illumina
ILMN
|
1.08 B | $ 162.32 | -3.42 % | $ 25.2 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 22.25 | -3.76 % | $ 1.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
1.04 B | $ 149.45 | -2.19 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 100.98 | -1.79 % | $ 6.82 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-460 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 10.9 | -3.63 % | $ 1.4 B | USA |
 |
Natera
NTRA
|
215 M | $ 215.31 | -3.06 % | $ 29.4 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 181.34 | -2.4 % | $ 8.99 B | USA |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.45 | -11.04 % | $ 435 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 454.25 | -0.97 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 154.33 | -2.22 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.57 | -2.56 % | $ 423 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 19.14 | -3.09 % | $ 428 M | USA |
 |
Personalis
PSNL
|
-74.9 M | $ 10.75 | -11.16 % | $ 959 M | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 6.67 | -4.85 % | $ 278 M | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.12 | -1.17 % | $ 4.87 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 265.15 | 1.6 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 69.22 | -6.37 % | $ 4.14 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 472.8 | -1.91 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.67 | -2.43 % | $ 241 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
653 M | $ 365.36 | -2.95 % | $ 21.8 B | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 8.9 | -2.41 % | $ 1.93 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 200.29 | 2.13 % | $ 22.2 B | USA |